Phenomenex Launches Spin-Off Company Neoteryx LLC
Phenomenex Inc. (Torrance, California, USA) has revealed it will be launching a spin-off company focusing on biological sampling called Neoteryx LLC.
Phenomenex Inc. (Torrance, California, USA) has revealed it will be launching a spin-off company focusing on biological sampling called Neoteryx LLC. Neoteryx is an independent company that aims to develop novel technologies and products for the collection, handling, and analysis of biological fluids in the pharmaceutical and clinical industries.
Neoteryx will use volumetric absorptive microsampling (VAMS) technology, developed at Phenomenex, to begin manufacturing products for the collection, handling, and analysis of biological fluids. This technology was developed over four years of internal research and development together with a co-development programme with major American and European pharmaceutical companies.
Mr. Fasha Mahjoor, Neoteryx CEO, commented: “I am excited to introduce Neoteryx, and even more so its novel technologies and products. The Mitra (RUO) Microsampling Device was officially launched at ASMS 2014 in Baltimore, Maryland [USA]. The response was overwhelmingly positive and all indications point to this device revolutionizing and simplifying how biological fluid sampling and analysis is performed”
For more information please visit www.phenomenex.com
The Complexity of Oligonucleotide Separations
January 9th 2025Peter Pellegrinelli, Applications Specialist at Advanced Materials Technology (AMT) explains the complexity of oligonucleotide separations due to the unique chemical properties of these molecules. Issues such as varying length, sequence complexity, and hydrophilic-hydrophobic characteristics make efficient separations difficult. Separation scientists are addressing these challenges by modifying mobile phase compositions, using varying ion-pairing reagents, and exploring alternative separation modes like HILIC and ion-exchange chromatography. Due to these complexities, AMT has introduced the HALO OLIGO column, which offers high-resolution, fast separations through its innovative Fused-Core® technology and high pH stability. Alongside explaining the new column, Peter looks to the future of these separations and what is next to come.
Frontage Laboratories Streamlines their Product Lifecycle Management with NuGenesis™ LMS
January 9th 2025Frontage laboratories wanted to improve the efficiency and quality of their operations and invest in ways to streamline their workflows. They implemented Waters NuGenesis™ Lab Management System (LMS) to progress their digital transformation journey and combine synergistic data, workflow, and sample management capabilities to support the entire product lifecycle from discovery through manufacturing.
The Intricacies of Oligonucleotide Separations
January 9th 2025Peter Pellegrinelli, Applications Specialist at Advanced Materials Technology (AMT) explains the complexity of oligonucleotide separations due to the unique chemical properties of these molecules. Issues such as varying length, sequence complexity, and hydrophilic-hydrophobic characteristics make efficient separations difficult. Separation scientists are addressing these challenges by modifying mobile phase compositions, using varying ion-pairing reagents, and exploring alternative separation modes like HILIC and ion-exchange chromatography. Due to these complexities, AMT has introduced the HALO OLIGO column, which offers high-resolution, fast separations through its innovative Fused-Core® technology and high pH stability. Alongside explaining the new column, Peter looks to the future of these separations and what is next to come.
